Maxim Group analyst Naz Rahman has reiterated their bullish stance on TLPH stock, giving a Buy rating on November 14. Naz Rahman has given his ...

A new scientific statement highlights new clinical data related to diagnosis, risk classification and treatment, emphasizing the need for tailored management strategies. Advances in cardiac imaging ...

Assessing when to initiate anticoagulation in atrial fibrillation is not improved by including gender, says the ESC in their ...

In this retrospective cohort of patients with atrial fibrillation (AF) who underwent transcatheter aortic valve replacement ...

Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...

DURHAM, NC, UNITED STATES, November 5, 2024 /EINPresswire / -- Entegrion, Inc., a leading developer of innovative solutions for clinical diagnosis and management of hemostasis, highlighted a newly ...

1 Despite strong evidence that treatment with direct oral anticoagulants prevents first ever stroke in people with atrial fibrillation, when to commence anticoagulation in patients with acute ...

Unfortunately, there is no consensus regarding the management of the same owing to the very small incidence in about 1.6% of all strokes. Many neurologists treat it with varying combinations of ...

Credit: meeboonstudio / Shutterstock. Patients with atrial fibrillation (AF) who have a stroke may benefit from taking anticoagulants earlier than is currently recommended. This is according to two ...

Intravenous thrombolytics are not recommended for acute ischaemic stroke in patients who have taken a direct oral anticoagulant (DOAC) within 48 hours before presentation because of the perceived ...

Through education, thought leadership, and partnerships with industry leaders, the AC Forum shapes the future of anticoagulation management to ensure the best outcomes for patients.

Participation Reinforces Cadrenal's Commitment to Innovation, Education and Improved Patient Outcomes with Anticoagulation Therapy PONTE VEDRA, Fla., Oct. 23, 2024 /PRNewswire/ -- Cadrenal ...